MMP11 and neoplasm: MMP11 expression was adversely correlated with the tumor mutation burden, as shown in Figure 10B. Furthermore, we used the Cancer Imaging Archive (TCIA) to confirm MMP11 expression for the prediction of immunotherapeutic benefits.